Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study

Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study

Abstract Background No data exist about the changes induced by the transition from first‐generation long‐acting insulins to second‐generation long‐acting analogues in the paediatric population. Objective To assess changes in insulin/carbohydrate ratio (I:CHO) after the first 6 months of degludec the...

Full description

Bibliographic Details
Main Authors: Stefano Tumini, Olimpia Iacono, Laura Comegna, Elisabetta Fioretti, Paola Guidone, Gabriella Levantini, Daniele Panichi, Milena Catenaro, Ilaria Rossi, Flavia Amaro, Giusi Graziano, Maria Chiara Rossi, Paola Cipriano
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
carbohydrates
continuous subcutaneous insulin infusion
degludec
glargine
insulin analogues
paediatric diabetes
Online Access:https://doi.org/10.1002/edm2.121

Internet

https://doi.org/10.1002/edm2.121

Similar Items